Resources

Publications

05/31/2023
- Oncology
Genetic Ancestry Associations With Somatic Mutations in a Real-world Cohort of Over 3,000 Patients With Prostate Cancer
ASCO 2023
05/26/2023
- Oncology
Pathway Enrichment Analysis in Tumors With High Mutation Burdens and Interferon-G Signature Expression: A Pan Cancer Analysis
ASCO 2023
05/26/2023
- Oncology
Integrated Clinical, Pathologic, and Genetic Data in a Racially Diverse Hereditary Breast Cancer Cohort
ASCO 2023
05/26/2023
- Oncology
Molecular Characterization of Resistance to Immune Checkpoint Inhibitor and Chemotherapy Treatment in Advanced Non-Small Cell Lung Cancer
ASCO 2023
05/26/2023
- Oncology
Clinical Outcomes Among Patients With Advanced Non-Small Cell Lung Cancer Who Received Targeted Therapy in a Real-World Setting
ASCO 2023
05/26/2023
- Oncology
Association of Tumor Homologous Recombination Deficiency (HRD) Score With Immune Checkpoint Inhibitor Benefit in Metastatic Clear Cell Renal Cell Carcinoma
ASCO 2023
05/26/2023
- Oncology
Renal Cell Carcinoma With Metastasis to the Pancreas: Genomic Signatures and Clinical Outcomes
ASCO 2023
05/26/2023
- Oncology
Next Generation Sequencing (NGS) Testing for Cancer Patients at a Safety NET Hospital
ASCO 2023
05/26/2023
- Oncology
RNA Sequencing To Characterize Pathways in EGFR-Mutated Non-Small Cell Lung Cancer
ASCO 2023
05/26/2023
- Oncology
Analysis on Real-World Chemotherapy Outcomes in Patients (Pts) With Tyrosine Kinase Inhibitor (TKI) Resistant Advanced EGFR-Mutant Non–Small-Cell Lung Cancer (NSCLC) in the United States
ASCO 2023

31 32 33